denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Education Program
Session: Follicular Lymphoma: Playing the Long Game
Hematology Disease Topics & Pathways:
Combination therapy, Antibody Therapy, Clinical Practice (Health Services and Quality), Lymphomas, Bispecific Antibody Therapy, B Cell lymphoma, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Chemotherapy, Diseases, Indolent lymphoma, Therapy sequence, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Non-Biological therapies, Monoclonal Antibody Therapy
Session: Follicular Lymphoma: Playing the Long Game
Hematology Disease Topics & Pathways:
Combination therapy, Antibody Therapy, Clinical Practice (Health Services and Quality), Lymphomas, Bispecific Antibody Therapy, B Cell lymphoma, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Chemotherapy, Diseases, Indolent lymphoma, Therapy sequence, Treatment Considerations, Biological therapies, Lymphoid Malignancies, Non-Biological therapies, Monoclonal Antibody Therapy
Sunday, December 8, 2024, 4:30 PM-5:45 PM
Disclosures: Trotman: Janssen: Research Funding; Cellectar: Research Funding; BMS: Research Funding; Beigene: Research Funding; Roche: Research Funding.
Previous Presentation
|
Next Presentation >>